Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial

Am Heart J. 2022 Dec:254:30-34. doi: 10.1016/j.ahj.2022.07.006. Epub 2022 Aug 4.

Abstract

Despite broad treatment recommendations, there are limited published reports comparing the efficacy of different antihypertensive agents in patients with isolated systolic hypertension or isolated diastolic hypertension. This study was a secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. We compared the use of chlorthalidone, amlodipine, or lisinopril on the primary outcome of combined coronary heart disease, stroke, or all-cause mortality in patients with isolated systolic hypertension or isolated diastolic hypertension.

Publication types

  • Letter

MeSH terms

  • Amlodipine / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Chlorthalidone / therapeutic use
  • Humans
  • Hypertension* / complications
  • Hypertension* / drug therapy
  • Isolated Systolic Hypertension*
  • Lisinopril / therapeutic use
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Chlorthalidone
  • Amlodipine
  • Lisinopril